𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serial measurements of Ca antigen in sera from patients with advanced malignant breast disease

✍ Scribed by F. Searle; S.M. Chantler; A.B. Goodall; T. Adam; K.D. Bagshawe; H.D.C. Mitchell; G.M. Boxer; P.M. Southall

Book ID
115826992
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
532 KB
Volume
186
Category
Article
ISSN
0009-8981

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence of antibodies to hepatitis a
Prevalence of antibodies to hepatitis a antigen in sera from patients with hematological malignancies
✍ E. Sandra McFarlane; Juan A. Embil πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 268 KB

## Abstract The prevalence of antibodies to hepatitis A (anti‐HA) was investigated in patients attending a clinic for hematological malignancies. Patients were divided into three age groups; the number with antibodies in each group was recorded. Of the 130 patients studied, 44% of those aged 4–26,

Correlation of serum levels of CA-549 to
Correlation of serum levels of CA-549 to disease status in posttreatment serial samples from breast cancer patients
✍ Kurtis R. Bray; Pramod K. Gaur πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 435 KB

CA-549 is a high molecular weight, circulating marker for breast cancer defined by its reactivity to monoclonal antibody BC4E 549. CA-549 has recently been shown to be elevated in the sera of 50% of advanced breast cancer patients (n = 80), as compared to < 2.0% of benign breast disease patients (n